{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T00:46:55Z","timestamp":1793666815169,"version":"4.5.1"},"reference-count":193,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,5,26]],"date-time":"2021-05-26T00:00:00Z","timestamp":1621987200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001590","name":"Health Research Board","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001590","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:p>Parkinson's disease (PD), the second most common neurodegenerative disease, is characterised by the motor symptoms of bradykinesia, rigidity and resting tremor and non-motor symptoms of sleep disturbances, constipation, and depression. Pathological hallmarks include neuroinflammation, degeneration of dopaminergic neurons in the substantia nigra pars compacta, and accumulation of misfolded \u03b1-synuclein proteins as intra-cytoplasmic Lewy bodies and neurites. Microglia and astrocytes are essential to maintaining homeostasis within the central nervous system (CNS), including providing protection through the process of gliosis. However, dysregulation of glial cells results in disruption of homeostasis leading to a chronic pro-inflammatory, deleterious environment, implicated in numerous CNS diseases. Recent evidence has demonstrated a role for peripheral immune cells, in particular T lymphocytes in the pathogenesis of PD. These cells infiltrate the CNS, and accumulate in the substantia nigra, where they secrete pro-inflammatory cytokines, stimulate surrounding immune cells, and induce dopaminergic neuronal cell death. Indeed, a greater understanding of the integrated network of communication that exists between glial cells and peripheral immune cells may increase our understanding of disease pathogenesis and hence provide novel therapeutic approaches.<\/jats:p>","DOI":"10.3389\/fneur.2021.666737","type":"journal-article","created":{"date-parts":[[2021,5,26]],"date-time":"2021-05-26T01:47:01Z","timestamp":1621993621000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":168,"title":["The Pathogenesis of Parkinson's Disease: A Complex Interplay Between Astrocytes, Microglia, and T Lymphocytes?"],"prefix":"10.3389","volume":"12","author":[{"given":"Adina N.","family":"MacMahon Copas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah F.","family":"McComish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean M.","family":"Fletcher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maeve A.","family":"Caldwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,5,26]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/S0733-8619(05)70259-0","article-title":"Epidemiology of Parkinson's disease","volume":"14","author":"Tanner","year":"1996","journal-title":"Neurol Clin."},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1007\/s10571-020-01027-6","article-title":"Role of microgliosis and NLRP3 inflammasome in Parkinson's disease pathogenesis and therapy","author":"de Araujo","year":"2021","journal-title":"Cell Mol Neurobiol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1176\/jnp.14.2.223","article-title":"An essay on the shaking palsy 1817","volume":"14","author":"Parkinson","year":"2002","journal-title":"J Neuropsychiatry Clin Neurosci."},{"key":"B4","doi-asserted-by":"publisher","first-page":"2283","DOI":"10.1093\/brain\/114.5.2283","article-title":"Ageing and Parkinson's disease: substantia nigra regional selectivity","volume":"114","author":"Fearnley","year":"1991","journal-title":"Brain."},{"key":"B5","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1076\/jhin.11.1.19.9106","article-title":"Friedrich heinrich lewy (1885-1950) and his work","volume":"11","author":"Holdorff","year":"2002","journal-title":"J Hist Neurosci."},{"key":"B6","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1038\/42166","article-title":"Alpha-synuclein in Lewy bodies","volume":"388","author":"Spillantini","year":"1997","journal-title":"Nature."},{"key":"B7","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1126\/science.276.5321.2045","article-title":"Mutation in the alpha-synuclein gene identified in families with Parkinson's disease","volume":"276","author":"Polymeropoulos","year":"1997","journal-title":"Science."},{"key":"B8","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/ng0298-106","article-title":"Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease","volume":"18","author":"Kruger","year":"1998","journal-title":"Nat Genet."},{"key":"B9","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1126\/science.1090278","article-title":"alpha-Synuclein locus triplication causes Parkinson's disease","volume":"302","author":"Singleton","year":"2003","journal-title":"Science."},{"key":"B10","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1002\/ana.10795","article-title":"The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia","volume":"55","author":"Zarranz","year":"2004","journal-title":"Ann Neurol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1002\/mds.26563","article-title":"Serum immune markers and disease progression in an incident Parkinson's disease cohort (ICICLE-PD)","volume":"31","author":"Williams-Gray","year":"2016","journal-title":"Mov Disord."},{"key":"B12","doi-asserted-by":"publisher","first-page":"4784268","DOI":"10.1155\/2018\/4784268","article-title":"Linking neuroinflammation and neurodegeneration in Parkinson's disease","volume":"2018","author":"Gelders","year":"2018","journal-title":"J Immunol Res."},{"key":"B13","doi-asserted-by":"publisher","first-page":"13276","DOI":"10.1038\/s41598-018-31517-z","article-title":"Cerebrospinal fluid concentrations of inflammatory markers in Parkinson's disease and atypical parkinsonian disorders","volume":"8","author":"Hall","year":"2018","journal-title":"Sci Rep."},{"key":"B14","doi-asserted-by":"publisher","first-page":"105028","DOI":"10.1016\/j.nbd.2020.105028","article-title":"Microglia and astrocyte dysfunction in parkinson's disease","volume":"144","author":"Kam","year":"2020","journal-title":"Neurobiol Dis."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1212\/WNL.38.8.1285","article-title":"Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains","volume":"38","author":"McGeer","year":"1988","journal-title":"Neurology."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1046\/j.1471-4159.2002.00928.x","article-title":"Microglial activation-mediated delayed and progressive degeneration of rat nigral dopaminergic neurons: relevance to Parkinson's disease","volume":"81","author":"Gao","year":"2002","journal-title":"J Neurochem."},{"key":"B17","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1097\/NEN.0b013e31829768d2","article-title":"alpha-Synuclein vaccination prevents the accumulation of parkinson disease-like pathologic inclusions in striatum in association with regulatory T cell recruitment in a rat model","volume":"72","author":"Sanchez-Guajardo","year":"2013","journal-title":"J Neuropathol Exp Neurol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"3116","DOI":"10.1093\/brain\/awz260","article-title":"Imidazoline 2 binding sites reflecting astroglia pathology in Parkinson's disease: an in vivo11C-BU99008 PET study","volume":"142","author":"Wilson","year":"2019","journal-title":"Brain."},{"key":"B19","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/S0079-6123(08)61770-7","article-title":"Astrocytes and Parkinson's disease","volume":"94","author":"Forno","year":"1992","journal-title":"Prog Brain Res."},{"key":"B20","doi-asserted-by":"publisher","first-page":"S161","DOI":"10.1212\/WNL.47.6_Suppl_3.161S","article-title":"Oxidative stress and the pathogenesis of Parkinson's disease","volume":"47","author":"Jenner","year":"1996","journal-title":"Neurology."},{"key":"B21","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1002\/glia.22935","article-title":"Evidence for a role of adaptive immune response in the disease pathogenesis of the MPTP mouse model of Parkinson's disease","volume":"64","author":"Martin","year":"2016","journal-title":"Glia."},{"key":"B22","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1111\/ejn.14290","article-title":"Immune system responses in Parkinson's disease: early and dynamic","volume":"49","author":"Tansey","year":"2019","journal-title":"Eur J Neurosci."},{"key":"B23","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1002\/cne.21974","article-title":"Equal numbers of neuronal and nonneuronal cells make the human brain an isometrically scaled-up primate brain","volume":"513","author":"Azevedo","year":"2009","journal-title":"J Comp Neurol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/S0166-2236(98)01349-6","article-title":"Tripartite synapses: glia, the unacknowledged partner","volume":"22","author":"Araque","year":"1999","journal-title":"Trends Neurosci."},{"key":"B25","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1126\/science.291.5504.657","article-title":"Control of synapse number by glia","volume":"291","author":"Ullian","year":"2001","journal-title":"Science."},{"key":"B26","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/nrn1824","article-title":"Astrocyte-endothelial interactions at the blood-brain barrier","volume":"7","author":"Abbott","year":"2006","journal-title":"Nat Rev Neurosci."},{"key":"B27","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1097\/00001756-199512000-00035","article-title":"GDNF reduces apoptosis in dopaminergic neurons in vitro.","volume":"7","author":"Clarkson","year":"1995","journal-title":"Neuroreport."},{"key":"B28","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1038\/373335a0","article-title":"Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivo","volume":"373","author":"Tomac","year":"1995","journal-title":"Nature"},{"key":"B29","doi-asserted-by":"publisher","first-page":"9651","DOI":"10.1523\/JNEUROSCI.0833-09.2009","article-title":"Mesencephalic astrocyte-derived neurotrophic factor is neurorestorative in rat model of Parkinson's disease","volume":"29","author":"Voutilainen","year":"2009","journal-title":"J Neurosci."},{"key":"B30","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s00401-009-0619-8","article-title":"Astrocytes: biology and pathology","volume":"119","author":"Sofroniew","year":"2010","journal-title":"Acta Neuropathol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/nature21029","article-title":"Neurotoxic reactive astrocytes are induced by activated microglia","volume":"541","author":"Liddelow","year":"2017","journal-title":"Nature."},{"key":"B32","doi-asserted-by":"publisher","first-page":"E1896","DOI":"10.1073\/pnas.1800165115","article-title":"Normal aging induces A1-like astrocyte reactivity","volume":"115","author":"Clarke","year":"2018","journal-title":"Proc Natl Acad Sci USA."},{"key":"B33","doi-asserted-by":"publisher","first-page":"9262","DOI":"10.1074\/jbc.M109.081125","article-title":"Direct transfer of alpha-synuclein from neuron to astroglia causes inflammatory responses in synucleinopathies","volume":"285","author":"Lee","year":"2010","journal-title":"J Biol Chem."},{"key":"B34","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1007\/s00401-017-1746-2","article-title":"alpha-Synuclein transfer between neurons and astrocytes indicates that astrocytes play a role in degradation rather than in spreading","volume":"134","author":"Loria","year":"2017","journal-title":"Acta Neuropathol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"11835","DOI":"10.1523\/JNEUROSCI.0983-17.2017","article-title":"Human astrocytes transfer aggregated alpha-synuclein via tunneling nanotubes","volume":"37","author":"Rostami","year":"2017","journal-title":"J Neurosci."},{"key":"B36","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1038\/s41591-018-0051-5","article-title":"Block of A1 astrocyte conversion by microglia is neuroprotective in models of Parkinson's disease","volume":"24","author":"Yun","year":"2018","journal-title":"Nat Med."},{"key":"B37","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/S1474-4422(19)30287-X","article-title":"The genetic architecture of Parkinson's disease","volume":"19","author":"Blauwendraat","year":"2020","journal-title":"Lancet Neurol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.neuron.2015.11.013","article-title":"Purification and characterization of progenitor and mature human astrocytes reveals transcriptional and functional differences with mouse","volume":"89","author":"Zhang","year":"2016","journal-title":"Neuron."},{"key":"B39","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.tins.2017.04.001","article-title":"The role of astrocyte dysfunction in Parkinson's disease pathogenesis","volume":"40","author":"Booth","year":"2017","journal-title":"Trends Neurosci."},{"key":"B40","doi-asserted-by":"publisher","first-page":"28823","DOI":"10.1038\/srep28823","article-title":"DJ-1 deficiency impairs glutamate uptake into astrocytes via the regulation of flotillin-1 and caveolin-1 expression","volume":"6","author":"Kim","year":"2016","journal-title":"Sci Rep."},{"key":"B41","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/j.nbd.2019.04.003","article-title":"A Parkinson's disease gene, DJ-1, regulates anti-inflammatory roles of astrocytes through prostaglandin D2 synthase expression","volume":"127","author":"Choi","year":"2019","journal-title":"Neurobiol Dis."},{"key":"B42","doi-asserted-by":"publisher","first-page":"2427","DOI":"10.1002\/glia.23482","article-title":"Parkin targets NOD2 to regulate astrocyte endoplasmic reticulum stress and inflammation","volume":"66","author":"Singh","year":"2018","journal-title":"Glia."},{"key":"B43","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s13041-016-0186-6","article-title":"PINK1 expression increases during brain development and stem cell differentiation, and affects the development of GFAP-positive astrocytes","volume":"9","author":"Choi","year":"2016","journal-title":"Mol Brain."},{"key":"B44","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1038\/s41598-017-18786-w","article-title":"Lack of PINK1 alters glia innate immune responses and enhances inflammation-induced, nitric oxide-mediated neuron death","volume":"8","author":"Sun","year":"2018","journal-title":"Sci Rep."},{"key":"B45","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1038\/s41531-019-0101-9","article-title":"PINK1 phosphorylates ubiquitin predominantly in astrocytes","volume":"5","author":"Barodia","year":"2019","journal-title":"NPJ Parkinsons Dis."},{"key":"B46","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1007\/s12035-020-02114-x","article-title":"Overexpression of alpha-synuclein reorganises growth factor profile of human astrocytes","volume":"58","author":"Sengul","year":"2021","journal-title":"Mol Neurobiol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/1756-6606-3-12","article-title":"Astrocytic expression of Parkinson's disease-related A53T alpha-synuclein causes neurodegeneration in mice","volume":"3","author":"Gu","year":"2010","journal-title":"Mol Brain."},{"key":"B48","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s40478-019-0716-4","article-title":"Parkinson's disease-associated LRRK2-G2019S mutant acts through regulation of SERCA activity to control ER stress in astrocytes","volume":"7","author":"Lee","year":"2019","journal-title":"Acta Neuropathol Commun."},{"key":"B49","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1002\/mds.27994","article-title":"Lysosome and inflammatory defects in GBA1-mutant astrocytes are normalized by LRRK2 inhibition","volume":"35","author":"Sanyal","year":"2020","journal-title":"Mov Disord."},{"key":"B50","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.stemcr.2018.12.011","article-title":"Patient-specific iPSC-derived astrocytes contribute to non-cell-autonomous neurodegeneration in Parkinson's disease","volume":"12","author":"di Domenico","year":"2019","journal-title":"Stem Cell Rep."},{"key":"B51","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.nbd.2019.05.006","article-title":"RNA sequencing reveals MMP2 and TGFB1 downregulation in LRRK2 G2019S Parkinson's iPSC-derived astrocytes","volume":"129","author":"Booth","year":"2019","journal-title":"Neurobiol Dis."},{"key":"B52","doi-asserted-by":"publisher","first-page":"14474","DOI":"10.1038\/s41598-020-71329-8","article-title":"Metabolic alterations in Parkinson's disease astrocytes","volume":"10","author":"Sonninen","year":"2020","journal-title":"Sci Rep."},{"key":"B53","doi-asserted-by":"publisher","first-page":"104647","DOI":"10.1016\/j.nbd.2019.104647","article-title":"A characterization of Gaucher iPS-derived astrocytes: potential implications for Parkinson's disease","volume":"134","author":"Aflaki","year":"2020","journal-title":"Neurobiol Dis."},{"key":"B54","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1126\/science.1077209","article-title":"Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism","volume":"299","author":"Bonifati","year":"2003","journal-title":"Science."},{"key":"B55","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1111\/j.1471-4159.2011.07175.x","article-title":"DJ-1 deficiency in astrocytes selectively enhances mitochondrial Complex I inhibitor-induced neurotoxicity","volume":"117","author":"Mullett","year":"2011","journal-title":"J Neurochem."},{"key":"B56","doi-asserted-by":"publisher","first-page":"2478","DOI":"10.1096\/fj.08-125153","article-title":"Regulation of astrocyte inflammatory responses by the Parkinson's disease-associated gene DJ-1","volume":"23","author":"Waak","year":"2009","journal-title":"FASEB J."},{"key":"B57","doi-asserted-by":"publisher","first-page":"11929","DOI":"10.1523\/JNEUROSCI.1860-14.2014","article-title":"An RNA-sequencing transcriptome and splicing database of glia, neurons, and vascular cells of the cerebral cortex","volume":"34","author":"Zhang","year":"2014","journal-title":"J Neurosci."},{"key":"B58","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1007\/s11481-014-9552-2","article-title":"Cinnamon treatment upregulates neuroprotective proteins Parkin and DJ-1 and protects dopaminergic neurons in a mouse model of Parkinson's disease","volume":"9","author":"Khasnavis","year":"2014","journal-title":"J Neuroimmune Pharmacol."},{"key":"B59","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/j.tips.2011.06.001","article-title":"Genetic mutations and functions of PINK1","volume":"32","author":"Kawajiri","year":"2011","journal-title":"Trends Pharmacol Sci."},{"key":"B60","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1111\/gtc.12066","article-title":"The principal PINK1 and Parkin cellular events triggered in response to dissipation of mitochondrial membrane potential occur in primary neurons","volume":"18","author":"Koyano","year":"2013","journal-title":"Genes Cells."},{"key":"B61","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1007\/s00702-019-02025-9","article-title":"alpha-Synuclein in Parkinson's disease: causal or bystander?","volume":"126","author":"Riederer","year":"2019","journal-title":"J Neural Transm."},{"key":"B62","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1007\/PL00007400","article-title":"NACP\/alpha-synuclein-positive filamentous inclusions in astrocytes and oligodendrocytes of Parkinson's disease brains","volume":"99","author":"Wakabayashi","year":"2000","journal-title":"Acta Neuropathol."},{"key":"B63","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/s00401-007-0244-3","article-title":"Development of alpha-synuclein immunoreactive astrocytes in the forebrain parallels stages of intraneuronal pathology in sporadic Parkinson's disease","volume":"114","author":"Braak","year":"2007","journal-title":"Acta Neuropathol."},{"key":"B64","doi-asserted-by":"publisher","first-page":"283","DOI":"10.4161\/oxim.3.4.12809","article-title":"Alpha-synuclein stimulation of astrocytes: potential role for neuroinflammation and neuroprotection","volume":"3","author":"Lee","year":"2010","journal-title":"Oxid Med Cell Longev."},{"key":"B65","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/j.neuron.2004.11.005","article-title":"Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology","volume":"44","author":"Zimprich","year":"2004","journal-title":"Neuron."},{"key":"B66","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.tins.2006.03.006","article-title":"LRRK2 in Parkinson's disease: protein domains and functional insights","volume":"29","author":"Mata","year":"2006","journal-title":"Trends Neurosci."},{"key":"B67","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/s41582-019-0301-2","article-title":"LRRK2 in Parkinson disease: challenges of clinical trials","volume":"16","author":"Tolosa","year":"2020","journal-title":"Nat Rev Neurol."},{"key":"B68","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1007\/s11481-017-9732-y","article-title":"TGF-beta1 neuroprotection via inhibition of microglial activation in a rat model of Parkinson's disease","volume":"12","author":"Chen","year":"2017","journal-title":"J Neuroimmune Pharmacol."},{"key":"B69","doi-asserted-by":"publisher","first-page":"949","DOI":"10.5966\/sctm.2016-0111","article-title":"The cleavage effect of mesenchymal stem cell and its derived matrix Metalloproteinase-2 on extracellular alpha-synuclein aggregates in parkinsonian models","volume":"6","author":"Oh","year":"2017","journal-title":"Stem Cells Transl Med."},{"key":"B70","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.neuint.2017.03.004","article-title":"Neurons and astrocytes in an infantile neuroaxonal dystrophy (INAD) mouse model show characteristic alterations in glutamate-induced Ca(2+) signaling","volume":"108","author":"Strokin","year":"2017","journal-title":"Neurochem Int."},{"key":"B71","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1111\/cns.12514","article-title":"Atp13a2 deficiency aggravates astrocyte-mediated neuroinflammation via NLRP3 inflammasome activation","volume":"22","author":"Qiao","year":"2016","journal-title":"CNS Neurosci Ther."},{"key":"B72","doi-asserted-by":"publisher","first-page":"8618","DOI":"10.1523\/JNEUROSCI.0954-20.2020","article-title":"Astrocytes protect human dopaminergic neurons from alpha-synuclein accumulation and propagation","volume":"40","author":"Tsunemi","year":"2020","journal-title":"J Neurosci."},{"key":"B73","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.15252\/embj.201593585","article-title":"Loss of FBXO7 (PARK15) results in reduced proteasome activity and models a parkinsonism-like phenotype in mice","volume":"35","author":"Vingill","year":"2016","journal-title":"EMBO J."},{"key":"B74","doi-asserted-by":"publisher","first-page":"8189","DOI":"10.1523\/JNEUROSCI.2218-08.2008","article-title":"Depletion of 26S proteasomes in mouse brain neurons causes neurodegeneration and Lewy-like inclusions resembling human pale bodies","volume":"28","author":"Bedford","year":"2008","journal-title":"J Neurosci."},{"key":"B75","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1042\/BCJ20160498","article-title":"Ubiquitin and Parkinson's disease through the looking glass of genetics","volume":"474","author":"Walden","year":"2017","journal-title":"Biochem J."},{"key":"B76","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/s10571-020-00849-8","article-title":"The role of VPS35 in the pathobiology of Parkinson's disease","volume":"41","author":"Sassone","year":"2020","journal-title":"Cell Mol Neurobiol"},{"key":"B77","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1038\/s41419-020-03228-9","article-title":"(D620N) VPS35 causes the impairment of Wnt\/beta-catenin signaling cascade and mitochondrial dysfunction in a PARK17 knockin mouse model","volume":"11","author":"Chiu","year":"2020","journal-title":"Cell Death Dis."},{"key":"B78","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1038\/nri.2017.125","article-title":"Microglia and macrophages in brain homeostasis and disease","volume":"18","author":"Li","year":"2018","journal-title":"Nat Rev Immunol."},{"key":"B79","doi-asserted-by":"publisher","first-page":"4216","DOI":"10.1523\/JNEUROSCI.3441-12.2013","article-title":"Microglia regulate the number of neural precursor cells in the developing cerebral cortex","volume":"33","author":"Cunningham","year":"2013","journal-title":"J Neurosci."},{"key":"B80","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1038\/ni.3253","article-title":"Phagocytosis of apoptotic cells in homeostasis","volume":"16","author":"Arandjelovic","year":"2015","journal-title":"Nat Immunol."},{"key":"B81","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.1016\/j.cell.2013.11.030","article-title":"Microglia promote learning-dependent synapse formation through brain-derived neurotrophic factor","volume":"155","author":"Parkhurst","year":"2013","journal-title":"Cell."},{"key":"B82","doi-asserted-by":"publisher","first-page":"12540","DOI":"10.1038\/ncomms12540","article-title":"Microglia contact induces synapse formation in developing somatosensory cortex","volume":"7","author":"Miyamoto","year":"2016","journal-title":"Nat Commun."},{"key":"B83","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/PREACCEPT-2025829283135633","article-title":"Microglial phenotypes and toll-like receptor 2 in the substantia nigra and hippocampus of incidental Lewy body disease cases and Parkinson's disease patients","volume":"2","author":"Doorn","year":"2014","journal-title":"Acta Neuropathol Commun."},{"key":"B84","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1186\/s12974-019-1682-2","article-title":"The potassium channel KCa3.1 represents a valid pharmacological target for microgliosis-induced neuronal impairment in a mouse model of Parkinson's disease","volume":"16","author":"Lu","year":"2019","journal-title":"J Neuroinflammation."},{"key":"B85","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1111\/nan.12644","article-title":"Peripheral inflammation exacerbates alpha-synuclein toxicity and neuropathology in Parkinson's models","volume":"47","author":"La Vitola","year":"2021","journal-title":"Neuropathol Appl Neurobiol."},{"key":"B86","doi-asserted-by":"publisher","first-page":"1818","DOI":"10.1002\/mds.27799","article-title":"Immunomodulatory drugs alleviate l-dopa-induced dyskinesia in a rat model of Parkinson's disease","volume":"34","author":"Boi","year":"2019","journal-title":"Mov Disord."},{"key":"B87","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1007\/s11481-020-09925-8","article-title":"Combined 1-Deoxynojirimycin and Ibuprofen treatment decreases microglial activation, phagocytosis and dopaminergic degeneration in MPTP-treated mice","volume":"16","author":"Costa","year":"2020","journal-title":"J Neuroimmune Pharmacol"},{"key":"B88","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1111\/jnc.14222","article-title":"DJ-1 deficiency impairs autophagy and reduces alpha-synuclein phagocytosis by microglia","volume":"143","author":"Nash","year":"2017","journal-title":"J Neurochem."},{"key":"B89","doi-asserted-by":"publisher","first-page":"e0151569","DOI":"10.1371\/journal.pone.0151569","article-title":"Microglia-derived cytokines\/chemokines are involved in the enhancement of LPS-induced loss of nigrostriatal dopaminergic neurons in DJ-1 Knockout mice","volume":"11","author":"Chien","year":"2016","journal-title":"PLoS ONE."},{"key":"B90","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1111\/jnc.12633","article-title":"DJ-1 deficiency triggers microglia sensitivity to dopamine toward a pro-inflammatory phenotype that is attenuated by rasagiline","volume":"129","author":"Trudler","year":"2014","journal-title":"J Neurochem."},{"key":"B91","doi-asserted-by":"publisher","first-page":"2990","DOI":"10.1007\/s12035-018-1264-9","article-title":"Loss of microglial parkin inhibits necroptosis and contributes to neuroinflammation","volume":"56","author":"Dion\u00edsio","year":"2019","journal-title":"Mol Neurobiol."},{"key":"B92","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1002\/glia.23337","article-title":"Parkin deficiency modulates NLRP3 inflammasome activation by attenuating an A20-dependent negative feedback loop","volume":"66","author":"Mouton-Liger","year":"2018","journal-title":"Glia."},{"key":"B93","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1186\/s12974-018-1171-z","article-title":"Lewy body-like alpha-synuclein inclusions trigger reactive microgliosis prior to nigral degeneration","volume":"15","author":"Duffy","year":"2018","journal-title":"J Neuroinflammation."},{"key":"B94","doi-asserted-by":"publisher","first-page":"e0162717","DOI":"10.1371\/journal.pone.0162717","article-title":"Alpha-Synuclein proteins promote pro-inflammatory cascades in microglia: stronger effects of the A53T mutant","volume":"11","author":"Hoenen","year":"2016","journal-title":"PLoS ONE."},{"key":"B95","doi-asserted-by":"publisher","first-page":"2304","DOI":"10.1016\/j.neurobiolaging.2015.03.015","article-title":"P2X7 receptor is critical in \u03b1-synuclein\u2013mediated microglial NADPH oxidase activation","volume":"36","author":"Jiang","year":"2015","journal-title":"Neurobiol Aging."},{"key":"B96","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.neurobiolaging.2020.02.017","article-title":"Leucine-rich repeat kinase-2 (LRRK2) modulates microglial phenotype and dopaminergic neurodegeneration","volume":"91","author":"Dwyer","year":"2020","journal-title":"Neurobiol Aging."},{"key":"B97","doi-asserted-by":"publisher","first-page":"5163","DOI":"10.1038\/s41467-020-18755-4","article-title":"Interferon-\u03b3 signaling synergizes with LRRK2 in neurons and microglia derived from human induced pluripotent stem cells","volume":"11","author":"Panagiotakopoulou","year":"2020","journal-title":"Nat Commun."},{"key":"B98","doi-asserted-by":"publisher","first-page":"e0210248","DOI":"10.1371\/journal.pone.0210248","article-title":"LRRK2 kinase plays a critical role in manganese-induced inflammation and apoptosis in microglia","volume":"14","author":"Kim","year":"2019","journal-title":"PLoS ONE."},{"key":"B99","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.neurobiolaging.2017.11.006","article-title":"Alteration of autophagy-related proteins in peripheral blood mononuclear cells of patients with Parkinson's disease","volume":"63","author":"Miki","year":"2018","journal-title":"Neurobiol Aging."},{"key":"B100","doi-asserted-by":"publisher","first-page":"2651","DOI":"10.1016\/j.jmb.2020.01.037","article-title":"Autophagy in Parkinson's disease","volume":"432","author":"Hou","year":"2020","journal-title":"J Mol Biol."},{"key":"B101","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.bbi.2020.10.010","article-title":"Impaired autophagy in microglia aggravates dopaminergic neurodegeneration by regulating NLRP3 inflammasome activation in experimental models of Parkinson's disease","volume":"91","author":"Qin","year":"2021","journal-title":"Brain Behav Immun."},{"key":"B102","doi-asserted-by":"publisher","first-page":"2193","DOI":"10.1080\/15548627.2020.1719723","article-title":"Microglial autophagy defect causes parkinson disease-like symptoms by accelerating inflammasome activation in mice","volume":"16","author":"Cheng","year":"2020","journal-title":"Autophagy."},{"key":"B103","doi-asserted-by":"publisher","first-page":"e22","DOI":"10.1038\/emm.2013.45","article-title":"Autophagic failure promotes the exocytosis and intercellular transfer of \u03b1-synuclein","volume":"45","author":"Lee","year":"2013","journal-title":"Exp Mol Med."},{"key":"B104","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.pneurobio.2018.09.003","article-title":"New insights into the complex role of mitochondria in Parkinson's disease","volume":"177","author":"Gr\u00fcnewald","year":"2019","journal-title":"Prog Neurobiol."},{"key":"B105","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.neuroscience.2020.06.001","article-title":"Down-regulation of DJ-1 augments neuroinflammation via Nrf2\/Trx1\/NLRP3 axis in MPTP-induced Parkinson's disease mouse model","volume":"442","author":"Ji","year":"2020","journal-title":"Neuroscience."},{"key":"B106","doi-asserted-by":"publisher","first-page":"593890","DOI":"10.3389\/fcell.2020.593890","article-title":"DJ-1 regulates microglial polarization through P62-Mediated TRAF6\/IRF5 signaling in cerebral ischemia-reperfusion","volume":"8","author":"Wang","year":"2020","journal-title":"Front Cell Dev Biol."},{"key":"B107","doi-asserted-by":"publisher","first-page":"a024091","DOI":"10.1101\/cshperspect.a024091","article-title":"Cell biology and pathophysiology of \u03b1-Synuclein","volume":"8","author":"Burr\u00e9","year":"2018","journal-title":"Cold Spring Harb Perspect Med."},{"key":"B108","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.nbd.2015.08.025","article-title":"Fc\u03b3RIIB mediates the inhibitory effect of aggregated \u03b1-synuclein on microglial phagocytosis","volume":"83","author":"Choi","year":"2015","journal-title":"Neurobiol Dis."},{"key":"B109","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.pneurobio.2018.06.010","article-title":"Non-cell-autonomous actions of \u03b1-synuclein: implications in glial synucleinopathies","volume":"169","author":"Lim","year":"2018","journal-title":"Prog Neurobiol."},{"key":"B110","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1007\/s11481-020-09926-7","article-title":"Neuroinflammatory responses and Parkinson' disease: pathogenic mechanisms and therapeutic targets","volume":"15","author":"Yang","year":"2020","journal-title":"J Neuroimmune Pharmacol."},{"key":"B111","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.1038\/ncomms2534","article-title":"Neuron-released oligomeric alpha-synuclein is an endogenous agonist of TLR2 for paracrine activation of microglia","volume":"4","author":"Kim","year":"2013","journal-title":"Nat Commun."},{"key":"B112","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1097\/WNR.0000000000000406","article-title":"Elevated neuronal alpha-synuclein promotes microglia activation after spinal cord ischemic\/reperfused injury","volume":"26","author":"Qiao","year":"2015","journal-title":"Neuroreport."},{"key":"B113","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1002\/jnr.24012","article-title":"Alpha-synuclein induces microglial cell migration through stimulating HIF-1alpha accumulation","volume":"95","author":"Qiao","year":"2017","journal-title":"J Neurosci Res."},{"key":"B114","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1002\/glia.22437","article-title":"Toll-like receptor 4 is required for alpha-synuclein dependent activation of microglia and astroglia","volume":"61","author":"Fellner","year":"2013","journal-title":"Glia."},{"key":"B115","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1084\/jem.20182191","article-title":"Fyn kinase regulates misfolded \u03b1-synuclein uptake and NLRP3 inflammasome activation in microglia","volume":"216","author":"Panicker","year":"2019","journal-title":"J Exp Med."},{"key":"B116","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.arr.2017.12.007","article-title":"The genetics of Parkinson disease","volume":"42","author":"Deng","year":"2018","journal-title":"Ageing Res Rev."},{"key":"B117","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.3389\/fneur.2020.01005","article-title":"Patient-derived midbrain organoids to explore the molecular basis of Parkinson's disease","volume":"11","author":"Galet","year":"2020","journal-title":"Front Neurol."},{"key":"B118","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1186\/1742-2094-9-261","article-title":"LRRK2 kinase inhibition prevents pathological microglial phagocytosis in response to HIV-1 Tat protein","volume":"9","author":"Marker","year":"2012","journal-title":"J Neuroinflammation."},{"key":"B119","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1016\/j.stemcr.2020.04.001","article-title":"LRRK2 is recruited to phagosomes and co-recruits RAB8 and RAB10 in human pluripotent stem cell-derived macrophages","volume":"14","author":"Lee","year":"2020","journal-title":"Stem Cell Rep."},{"key":"B120","doi-asserted-by":"publisher","first-page":"e104862","DOI":"10.15252\/embj.2020104862","article-title":"LRRK2 and Rab10 coordinate macropinocytosis to mediate immunological responses in phagocytes","volume":"39","author":"Liu","year":"2020","journal-title":"EMBO J."},{"key":"B121","doi-asserted-by":"publisher","first-page":"E5164","DOI":"10.1073\/pnas.1718946115","article-title":"Regulation of myeloid cell phagocytosis by LRRK2 via WAVE2 complex stabilization is altered in Parkinson's disease","volume":"115","author":"Kim","year":"2018","journal-title":"Proc Natl Acad Sci USA."},{"key":"B122","doi-asserted-by":"publisher","first-page":"171","DOI":"10.5607\/en.2018.27.3.171","article-title":"LRRK2 kinase activity induces mitochondrial fission in microglia via Drp1 and modulates neuroinflammation","volume":"27","author":"Ho","year":"2018","journal-title":"Exp Neurobiol."},{"key":"B123","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1523\/JNEUROSCI.5601-11.2012","article-title":"LRRK2 inhibition attenuates microglial inflammatory responses","volume":"32","author":"Moehle","year":"2012","journal-title":"J Neurosci."},{"key":"B124","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.nbd.2019.05.012","article-title":"Transcriptome analysis of LRRK2 knock-out microglia cells reveals alterations of inflammatory- and oxidative stress-related pathways upon treatment with \u03b1-synuclein fibrils","volume":"129","author":"Russo","year":"2019","journal-title":"Neurobiol Dis."},{"key":"B125","doi-asserted-by":"publisher","first-page":"eaay0399","DOI":"10.1126\/scitranslmed.aay0399","article-title":"LRRK2 mediates microglial neurotoxicity via NFATc2 in rodent models of synucleinopathies","volume":"12","author":"Kim","year":"2020","journal-title":"Sci Transl Med."},{"key":"B126","doi-asserted-by":"publisher","first-page":"6640","DOI":"10.1093\/hmg\/ddv369","article-title":"Glucocerebrosidase 1 deficient Danio rerio mirror key pathological aspects of human Gaucher disease and provide evidence of early microglial activation preceding alpha-synuclein-independent neuronal cell death","volume":"24","author":"Keatinge","year":"2015","journal-title":"Hum Mol Genet."},{"key":"B127","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/nature21368","article-title":"Complement drives glucosylceramide accumulation and tissue inflammation in Gaucher disease","volume":"543","author":"Pandey","year":"2017","journal-title":"Nature."},{"key":"B128","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.neulet.2013.01.044","article-title":"A novel and functional variant within the ATG5 gene promoter in sporadic Parkinson's disease","volume":"538","author":"Chen","year":"2013","journal-title":"Neurosci Lett."},{"key":"B129","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1016\/j.molimm.2003.10.005","article-title":"Innate immunity: an overview","volume":"40","author":"Beutler","year":"2004","journal-title":"Mol Immunol."},{"key":"B130","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1152\/advan.00066.2013","article-title":"T cell responses: naive to memory and everything in between","volume":"37","author":"Pennock","year":"2013","journal-title":"Adv Physiol Educ."},{"key":"B131","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1038\/nm.2621","article-title":"Dysregulation of immune homeostasis in autoimmune diseases","volume":"18","author":"Kuchroo","year":"2012","journal-title":"Nat Med."},{"key":"B132","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1038\/jcbfm.2015.32","article-title":"Striatal blood-brain barrier permeability in Parkinson's disease","volume":"35","author":"Gray","year":"2015","journal-title":"J Cereb Blood Flow Metab."},{"key":"B133","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/nrneurol.2017.188","article-title":"Blood-brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders","volume":"14","author":"Sweeney","year":"2018","journal-title":"Nat Rev Neurol."},{"key":"B134","doi-asserted-by":"publisher","first-page":"593026","DOI":"10.3389\/fphys.2020.593026","article-title":"Blood-brain barrier leakage is increased in Parkinson's disease","volume":"11","author":"Al-Bachari","year":"2020","journal-title":"Front Physiol."},{"key":"B135","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1186\/s12974-019-1606-1","article-title":"Regulatory impairment in untreated Parkinson's disease is not restricted to Tregs: other regulatory populations are also involved","volume":"16","author":"Alvarez-Luquin","year":"2019","journal-title":"J Neuroinflammation."},{"key":"B136","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.parkreldis.2005.07.005","article-title":"Alterations of T-lymphocyte populations in Parkinson disease","volume":"11","author":"Baba","year":"2005","journal-title":"Parkinsonism Relat Disord."},{"key":"B137","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/S0165-5728(00)00422-7","article-title":"Lymphocyte populations in Parkinson's disease and in rat models of parkinsonism","volume":"113","author":"Bas","year":"2001","journal-title":"J Neuroimmunol."},{"key":"B138","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1172\/JCI36470","article-title":"Infiltration of CD4+ lymphocytes into the brain contributes to neurodegeneration in a mouse model of Parkinson disease","volume":"119","author":"Brochard","year":"2009","journal-title":"J Clin Invest."},{"key":"B139","doi-asserted-by":"publisher","first-page":"3633","DOI":"10.1038\/ncomms4633","article-title":"MHC-I expression renders catecholaminergic neurons susceptible to T-cell-mediated degeneration","volume":"5","author":"Cebrian","year":"2014","journal-title":"Nat Commun."},{"key":"B140","doi-asserted-by":"publisher","first-page":"9592","DOI":"10.1523\/JNEUROSCI.5610-12.2013","article-title":"MHCII is required for alpha-synuclein-induced activation of microglia, CD4 T cell proliferation, dopaminergic neurodegeneration","volume":"33","author":"Harms","year":"2013","journal-title":"J Neurosci."},{"key":"B141","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1186\/s12974-018-1248-8","article-title":"Parkinson's disease patients have a complex phenotypic and functional Th1 bias: cross-sectional studies of CD4+ Th1\/Th2\/T17 and Treg in drug-naive and drug-treated patients","volume":"15","author":"Kustrimovic","year":"2018","journal-title":"J Neuroinflammation."},{"key":"B142","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.1038\/s41467-020-15626-w","article-title":"alpha-Synuclein-specific T cell reactivity is associated with preclinical and early Parkinson's disease","volume":"11","author":"Lindestam Arlehamn","year":"2020","journal-title":"Nat Commun."},{"key":"B143","doi-asserted-by":"publisher","first-page":"7762","DOI":"10.1007\/s12035-016-0249-9","article-title":"Th17 cells induce dopaminergic neuronal death via LFA-1\/ICAM-1 interaction in a mouse model of Parkinson's disease","volume":"54","author":"Liu","year":"2017","journal-title":"Mol Neurobiol."},{"key":"B144","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1016\/j.bbi.2019.07.026","article-title":"IL-17A exacerbates neuroinflammation and neurodegeneration by activating microglia in rodent models of Parkinson's disease","volume":"81","author":"Liu","year":"2019","journal-title":"Brain Behav Immun."},{"key":"B145","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1189\/jlb.0507296","article-title":"Neuroprotective activities of CD4+CD25+ regulatory T cells in an animal model of Parkinson's disease","volume":"82","author":"Reynolds","year":"2007","journal-title":"J Leukoc Biol."},{"key":"B146","doi-asserted-by":"publisher","first-page":"2261","DOI":"10.4049\/jimmunol.0901852","article-title":"Regulatory T cells attenuate Th17 cell-mediated nigrostriatal dopaminergic neurodegeneration in a model of Parkinson's disease","volume":"184","author":"Reynolds","year":"2010","journal-title":"J Immunol."},{"key":"B147","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1186\/s12974-016-0632-5","article-title":"Infiltrating T lymphocytes reduce myeloid phagocytosis activity in synucleinopathy model","volume":"13","author":"Sommer","year":"2016","journal-title":"J Neuroinflammation."},{"key":"B148","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.stem.2018.06.015","article-title":"Th17 lymphocytes induce neuronal cell death in a human iPSC-based model of Parkinson's disease","volume":"23","author":"Sommer","year":"2018","journal-title":"Cell Stem Cell."},{"key":"B149","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.jneuroim.2012.07.015","article-title":"Reduced T helper and B lymphocytes in Parkinson's disease","volume":"252","author":"Stevens","year":"2012","journal-title":"J Neuroimmunol."},{"key":"B150","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1038\/nature22815","article-title":"T cells from patients with Parkinson's disease recognize alpha-synuclein peptides","volume":"546","author":"Sulzer","year":"2017","journal-title":"Nature."},{"key":"B151","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1097\/NEN.0b013e31818e5e99","article-title":"Targeted overexpression of human alpha-synuclein triggers microglial activation and an adaptive immune response in a mouse model of Parkinson disease","volume":"67","author":"Theodore","year":"2008","journal-title":"J Neuropathol Exp Neurol."},{"key":"B152","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/ene.14108","article-title":"Parkinson disease","volume":"27","author":"Balestrino","year":"2020","journal-title":"Eur J Neurol."},{"key":"B153","doi-asserted-by":"publisher","first-page":"3077","DOI":"10.1093\/brain\/awaa238","article-title":"Brain-first versus body-first Parkinson's disease: a multimodal imaging case-control study","volume":"143","author":"Horsager","year":"2020","journal-title":"Brain."},{"key":"B154","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1126\/science.1249161","article-title":"PINK1 loss-of-function mutations affect mitochondrial complex I activity via NdufA10 ubiquinone uncoupling","volume":"344","author":"Morais","year":"2014","journal-title":"Science."},{"key":"B155","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1002\/mds.26488","article-title":"Cdk5-dependent activation of neuronal inflammasomes in Parkinson's disease","volume":"31","author":"Zhang","year":"2016","journal-title":"Mov Disord."},{"key":"B156","doi-asserted-by":"publisher","first-page":"577089","DOI":"10.1016\/j.jneuroim.2019.577089","article-title":"Inflammasome and \u03b1-synuclein in Parkinson's disease: a cross-sectional study","volume":"338","author":"Chatterjee","year":"2020","journal-title":"J Neuroimmunol."},{"key":"B157","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/s41531-017-0032-2","article-title":"Mitochondrial impairment in microglia amplifies NLRP3 inflammasome proinflammatory signaling in cell culture and animal models of Parkinson's disease","volume":"3","author":"Sarkar","year":"2017","journal-title":"NPJ Parkinsons Dis."},{"key":"B158","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.molcel.2015.08.016","article-title":"The PINK1-PARKIN mitochondrial ubiquitylation pathway drives a program of OPTN\/NDP52 recruitment and tbk1 activation to promote mitophagy","volume":"60","author":"Heo","year":"2015","journal-title":"Mol Cell."},{"key":"B159","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1186\/s12974-017-0928-0","article-title":"Progression of pathology in PINK1-deficient mouse brain from splicing via ubiquitination, ER stress, and mitophagy changes to neuroinflammation","volume":"14","author":"Torres-Odio","year":"2017","journal-title":"J Neuroinflammation."},{"key":"B160","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.cell.2016.05.039","article-title":"Parkinson's disease-related proteins PINK1 and parkin repress mitochondrial antigen presentation","volume":"166","author":"Matheoud","year":"2016","journal-title":"Cell."},{"key":"B161","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1038\/s41586-019-1405-y","article-title":"Intestinal infection triggers Parkinson's disease-like symptoms in Pink1(-\/-) mice","volume":"571","author":"Matheoud","year":"2019","journal-title":"Nature."},{"key":"B162","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3233\/JPD-2011-11041","article-title":"Loss-of-function rodent models for parkin and PINK1","volume":"1","author":"Oliveras-Salva","year":"2011","journal-title":"J Parkinsons Dis."},{"key":"B163","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1016\/j.cell.2016.11.018","article-title":"Gut microbiota regulate motor deficits and neuroinflammation in a model of Parkinson's disease","volume":"167","author":"Sampson","year":"2016","journal-title":"Cell."},{"key":"B164","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1038\/ncomms2260","article-title":"T-bet and GATA3 orchestrate Th1 and Th2 differentiation through lineage-specific targeting of distal regulatory elements","volume":"3","author":"Kanhere","year":"2012","journal-title":"Nat Commun."},{"key":"B165","doi-asserted-by":"publisher","first-page":"13","DOI":"10.3389\/fneur.2019.00013","article-title":"Do Th17 Lymphocytes and IL-17 contribute to Parkinson's disease? A systematic review of available evidence","volume":"10","author":"Storelli","year":"2019","journal-title":"Front Neurol."},{"key":"B166","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1038\/nri2433","article-title":"Cytokine-mediated regulation of antimicrobial proteins","volume":"8","author":"Kolls","year":"2008","journal-title":"Nat Rev Immunol."},{"key":"B167","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1038\/nri.2017.118","article-title":"TH2 cell development and function","volume":"18","author":"Walker","year":"2018","journal-title":"Nat Rev Immunol."},{"key":"B168","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1097\/COC.0000000000000239","article-title":"CTLA-4 and PD-1 pathways: similarities, differences, and implications of their inhibition","volume":"39","author":"Buchbinder","year":"2016","journal-title":"Am J Clin Oncol."},{"key":"B169","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/s41531-017-0010-8","article-title":"LRRK2 levels in immune cells are increased in Parkinson's disease","volume":"3","author":"Cook","year":"2017","journal-title":"NPJ Parkinsons Dis."},{"key":"B170","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1186\/s12974-020-01776-7","article-title":"Astrocytes have the capacity to act as antigen-presenting cells in the Parkinson's disease brain","volume":"17","author":"Rostami","year":"2020","journal-title":"J Neuroinflammation."},{"key":"B171","doi-asserted-by":"publisher","first-page":"952","DOI":"10.3389\/fimmu.2018.00952","article-title":"LFA-1 in T cell migration and differentiation","volume":"9","author":"Walling","year":"2018","journal-title":"Front Immunol."},{"key":"B172","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1186\/s12974-017-0978-3","article-title":"Effectors of Th1 and Th17 cells act on astrocytes and augment their neuroinflammatory properties","volume":"14","author":"Prajeeth","year":"2017","journal-title":"J Neuroinflammation."},{"key":"B173","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1007\/BF00334673","article-title":"Expression of intercellular adhesion molecule (ICAM)-1 by a subset of astrocytes in Alzheimer disease and some other degenerative neurological disorders","volume":"85","author":"Akiyama","year":"1993","journal-title":"Acta Neuropathol."},{"key":"B174","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.expneurol.2005.10.034","article-title":"Role of ICAM-1 in persisting inflammation in Parkinson disease and MPTP monkeys","volume":"197","author":"Miklossy","year":"2006","journal-title":"Exp Neurol."},{"key":"B175","doi-asserted-by":"publisher","first-page":"41779","DOI":"10.1038\/srep41779","article-title":"IL-17 induces reactive astrocytes and up-regulation of vascular endothelial growth factor (VEGF) through JAK\/STAT signaling","volume":"7","author":"You","year":"2017","journal-title":"Sci Rep."},{"key":"B176","doi-asserted-by":"crossref","first-page":"409","DOI":"10.4049\/jimmunol.161.1.409","article-title":"Enhancing effect of IL-17 on IL-1-induced IL-6 and leukemia inhibitory factor production by rheumatoid arthritis synoviocytes and its regulation by Th2 cytokines","volume":"161","author":"Chabaud","year":"1998","journal-title":"J Immunol."},{"key":"B177","doi-asserted-by":"publisher","first-page":"2176","DOI":"10.1002\/1529-0131(200109)44:9<2176::AID-ART371>3.0.CO;2-4","article-title":"Interleukin-17 enhances tumor necrosis factor alpha-induced synthesis of interleukins 1,6, and 8 in skin and synovial fibroblasts: a possible role as a \u201cfine-tuning cytokine\u201d in inflammation processes","volume":"44","author":"Katz","year":"2001","journal-title":"Arthritis Rheum."},{"key":"B178","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1038\/nri2586","article-title":"Structure and signalling in the IL-17 receptor family","volume":"9","author":"Gaffen","year":"2009","journal-title":"Nat Rev Immunol."},{"key":"B179","doi-asserted-by":"publisher","first-page":"4898","DOI":"10.4049\/jimmunol.1000142","article-title":"IL-17 enhancement of the IL-6 signaling cascade in astrocytes","volume":"184","author":"Ma","year":"2010","journal-title":"J Immunol."},{"key":"B180","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.3389\/fimmu.2019.01726","article-title":"Additive or synergistic interactions between IL-17A or IL-17F and TNF or IL-1beta depend on the cell type","volume":"10","author":"Noack","year":"2019","journal-title":"Front Immunol."},{"key":"B181","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.1016\/S0140-6736(17)31585-4","article-title":"Exenatide once weekly versus placebo in Parkinson's disease: a randomised, double-blind, placebo-controlled trial","volume":"390","author":"Athauda","year":"2017","journal-title":"Lancet."},{"key":"B182","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1001\/jamaneurol.2018.1487","article-title":"Safety and tolerability of multiple ascending doses of PRX002\/RG7935, an anti-alpha-synuclein monoclonal antibody, in patients with parkinson disease: a randomized clinical trial","volume":"75","author":"Jankovic","year":"2018","journal-title":"JAMA Neurol."},{"key":"B183","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1002\/mds.27738","article-title":"Randomized phase I clinical trial of anti-alpha-synuclein antibody BIIB054","volume":"34","author":"Brys","year":"2019","journal-title":"Mov Disord."},{"key":"B184","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/S1474-4422(20)30136-8","article-title":"Safety and immunogenicity of the alpha-synuclein active immunotherapeutic PD01A in patients with Parkinson's disease: a randomised, single-blinded, phase 1 trial","volume":"19","author":"Volc","year":"2020","journal-title":"Lancet Neurol."},{"key":"B185","doi-asserted-by":"publisher","first-page":"e040527","DOI":"10.1136\/bmjopen-2020-040527","article-title":"Azathioprine immunosuppression and disease modification in Parkinson's disease (AZA-PD): a randomised double-blind placebo-controlled phase II trial protocol","volume":"10","author":"Greenland","year":"2020","journal-title":"BMJ Open."},{"key":"B186","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1038\/s41531-017-0013-5","article-title":"Evaluation of the safety and immunomodulatory effects of sargramostim in a randomized, double-blind phase 1 clinical Parkinson's disease trial","volume":"3","author":"Gendelman","year":"2017","journal-title":"NPJ Parkinsons Dis."},{"key":"B187","doi-asserted-by":"publisher","first-page":"e22035","DOI":"10.1097\/MD.0000000000022035","article-title":"Fecal microbiota transplantation therapy for Parkinson's disease: a preliminary study","volume":"99","author":"Xue","year":"2020","journal-title":"Medicine."},{"key":"B188","doi-asserted-by":"publisher","first-page":"e16163","DOI":"10.1097\/MD.0000000000016163","article-title":"Fecal microbiota transplantation to treat Parkinson's disease with constipation: a case report","volume":"98","author":"Huang","year":"2019","journal-title":"Medicine."},{"key":"B189","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1016\/j.it.2020.07.006","article-title":"Microglia and astrocytes in disease: dynamic duo or partners in crime?","volume":"41","author":"Liddelow","year":"2020","journal-title":"Trends Immunol."},{"key":"B190","doi-asserted-by":"publisher","first-page":"20170214","DOI":"10.1098\/rstb.2017.0214","article-title":"Generation of defined neural populations from pluripotent stem cells","volume":"373","author":"McComish","year":"2018","journal-title":"Philos Trans R Soc Lond B Biol Sci."},{"key":"B191","doi-asserted-by":"publisher","first-page":"1247125","DOI":"10.1126\/science.1247125","article-title":"Organogenesis in a dish: modeling development and disease using organoid technologies","volume":"345","author":"Lancaster","year":"2014","journal-title":"Science."},{"key":"B192","doi-asserted-by":"publisher","first-page":"4167","DOI":"10.1038\/s41467-018-06684-2","article-title":"Microglia innately develop within cerebral organoids","volume":"9","author":"Ormel","year":"2018","journal-title":"Nat Commun."},{"key":"B193","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1038\/s41583-020-0263-9","article-title":"Immune cell regulation of glia during CNS injury and disease","volume":"21","author":"Greenhalgh","year":"2020","journal-title":"Nat Rev Neurosci."}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2021.666737\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,4]],"date-time":"2023-11-04T00:52:41Z","timestamp":1699059161000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2021.666737\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,26]]},"references-count":193,"alternative-id":["10.3389\/fneur.2021.666737"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2021.666737","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,26]]},"article-number":"666737"}}